KEMRI and NEC Announce Trials on Biometric-based Vaccination Management System for Newborn Children in Kenya
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
NAIROBI, Kenya & TOKYO -- Businesswire -- The Kenya Medical Research Institute (KEMRI), NEC Corporation (NEC; TOKYO: 6701) and Nagasaki University have developed a digital biometric-based vaccination management system for newborn children in Kenya. Validation of this system is taking place through KEMRI with a clinical trial that began in September 2022 at the Kinango Sub-County Hospital in Kwale.
The digital system being provided by NEC, a leader in the integration of IT and network technologies, and KEMRI, one of Africa’s leading research Institutions, will effectively and seamlessly manage vaccination history and scheduling using fingerprint identification for newborn children and voice recognition for caregivers.
This technology marks the first time that biometric identification is being used at a hospital to identify newborn children at the time of vaccination, including those immediately after delivery (*1).
In terms of background, many children around the world continue to lose their lives at a very young age. In 2020 alone, approximately 5 million children died before reaching their fifth birthday. Furthermore, about half of these children under the age of five, or 2.4 million children, passed away within 28 days of birth, with many of the deaths considered preventable (*2).
Meanwhile, in some regions in the world, the use of digital technology has not advanced due to delays in the development of electricity and telecommunications infrastructure. In these regions, medical services may only be recorded by hand. In such cases, health care providers cannot easily ascertain which medical services are needed for the caregivers and children who visit their hospitals, which is one of the factors hindering efforts to ensure that children receive the vaccinations they need.
The new technology combines fingerprint identification for children and voice recognition for caregivers to confirm not only their identity, but also to reliably manage vaccination histories and schedules, thereby promoting the implementation of appropriate vaccinations for newborns and children during the first 24 months of life. Going forward, demonstration tests that network multiple hospitals will begin, aiming for full-scale introduction throughout Kenya by the end of 2023, and more international deployment in the future.
Voice and fingerprint data will be deleted after completion of the trial.
Link to press release: https://www.nec.com/en/press/202302/global_20230207_01.html
Notes:
(*1) NEC research as of February 7, 2023 (*2) Source: Levels and trends in child mortality, Report 2021, UN-IGME https://data.unicef.org/resources/levels-and-trends-in-child-mortality/
View source version on businesswire.com: https://www.businesswire.com/news/home/20230206005304/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:NEC Corporation
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 삼성전자 ‘모두를 위한 AI’… AI 라이프 솔루션 공개 - 뉴스와이어
- 현대엘리베이터, UAM 핵심 ‘버티포트’ 본격 개발 나선다 - 뉴스와이어
- 도전의 시작, 혁신의 출발… 5월 15일 국토교통기술대전 개막 - 뉴스와이어
- 분홍 립스틱과 초록 나무 심기: 메리케이, 루이스빌에서 특별한 식목 행사로 지속 가능한 아름다
- 삼성SDS, 생성형 AI로 인천국제공항공사 업무 혁신한다 - 뉴스와이어
- Pink Lipsticks and Green Thumbs: Mary Kay Inc. Celebrates 60 Years of Sustainable Beauty With Special Tree Planting Event in Lew
- 넷앱과 레노버, 생성형 AI에 최적화된 컨버지드 인프라 솔루션 제공 - 뉴스와이어
- Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting - 뉴스와이어
- 셉톤, 코이토와 중요한 엔지니어링 계약 발표 - 뉴스와이어
- 킹 파이살 전문 병원 겸 연구 센터, 전략적 혁신 추진하는 가운데 신규 부사장 선임 - 뉴스와이어